Last year, I made nice gains from this ticker.
As you can see in the chart, it has taken a beating.
It gave me false signals in March that it was rebounding.
It is, again, giving me signals but this time the signals are quite a bit more impressive. Instead of meandering its way above key levels, yesterday it made a power move through the level.
It is now on its volume shelf and it will run into its next bag holders around $155, where I assume it will take time to digest that level before again moving higher.
For now, I am moderately adding to my position with patience.
After $157 I will get more aggressive, with tight stop loss, to ride this stock to reach all time highs (above $220).
Of my three genome stocks that I hold and play, CRSP is the strongest and healthiest play that has the highest confidence.
Because I have been burned by this before, I use caution and discipline and do not enter without hitting key levels. It can just as easily reverse on you and the losses are stomach churning.
As you can see in the chart, it has taken a beating.
It gave me false signals in March that it was rebounding.
It is, again, giving me signals but this time the signals are quite a bit more impressive. Instead of meandering its way above key levels, yesterday it made a power move through the level.
It is now on its volume shelf and it will run into its next bag holders around $155, where I assume it will take time to digest that level before again moving higher.
For now, I am moderately adding to my position with patience.
After $157 I will get more aggressive, with tight stop loss, to ride this stock to reach all time highs (above $220).
Of my three genome stocks that I hold and play, CRSP is the strongest and healthiest play that has the highest confidence.
Because I have been burned by this before, I use caution and discipline and do not enter without hitting key levels. It can just as easily reverse on you and the losses are stomach churning.
better not bitter
Wyłączenie odpowiedzialności
Informacje i publikacje przygotowane przez TradingView lub jego użytkowników, prezentowane na tej stronie, nie stanowią rekomendacji ani porad handlowych, inwestycyjnych i finansowych i nie powinny być w ten sposób traktowane ani wykorzystywane. Więcej informacji na ten temat znajdziesz w naszym Regulaminie.
better not bitter
Wyłączenie odpowiedzialności
Informacje i publikacje przygotowane przez TradingView lub jego użytkowników, prezentowane na tej stronie, nie stanowią rekomendacji ani porad handlowych, inwestycyjnych i finansowych i nie powinny być w ten sposób traktowane ani wykorzystywane. Więcej informacji na ten temat znajdziesz w naszym Regulaminie.